Schott C, Arnaldi M, Baker C, Wang J, McIntyre A, Colaiacovo S
Kidney Int Rep. 2025; 10(2):574-590.
PMID: 39990878
PMC: 11843117.
DOI: 10.1016/j.ekir.2024.11.004.
Kang S, Gulati R, Moise N, Hur C, Elkin E
Radiology. 2025; 314(1):e233448.
PMID: 39807974
PMC: 11783158.
DOI: 10.1148/radiol.233448.
Speiser J, Kerr W, Ziegler A
Neurology. 2024; 103(7):e209861.
PMID: 39236270
PMC: 11379123.
DOI: 10.1212/WNL.0000000000209861.
Rapoport C, Masser-Frye D, Mehta S, Choi A, Olfus S, Korhummel M
Cancer Rep (Hoboken). 2024; 7(9):e2119.
PMID: 39233650
PMC: 11375323.
DOI: 10.1002/cnr2.2119.
Hodan R, Picus M, Stanclift C, Ormond K, Pichardo J, Kurian A
J Community Genet. 2024; 15(4):363-374.
PMID: 38814439
PMC: 11410745.
DOI: 10.1007/s12687-024-00712-z.
Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for pediatric diagnostic testing.
Smith H, Rubanovich C, Robinson J, Levchenko A, Classen S, Malek J
Genet Med. 2024; 26(8):101146.
PMID: 38676451
PMC: 11298290.
DOI: 10.1016/j.gim.2024.101146.
Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study.
Cernat A, Samaan Z, Abelson J, Ramdyal A, Shaikh H, Vanstone M
J Community Genet. 2024; 15(3):293-309.
PMID: 38587601
PMC: 11217204.
DOI: 10.1007/s12687-024-00705-y.
Measuring health-related quality of life in children with suspected genetic conditions: validation of the PedsQL proxy-report versions.
Smith H, Leo M, Goddard K, Muessig K, Angelo F, Knight S
Qual Life Res. 2024; 33(6):1541-1553.
PMID: 38472717
PMC: 11116065.
DOI: 10.1007/s11136-024-03623-1.
Moving to the Middle Ground: Redefining Genomic Utility to Expand Understanding of Familial Benefit.
Brothers K, Cooper G, McNamara K, Lemke A, Timmons J, Rich C
Ethics Hum Res. 2024; 46(1):43-48.
PMID: 38240400
PMC: 11173350.
DOI: 10.1002/eahr.500199.
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care.
Vassy J, Brunette C, Lebo M, MacIsaac K, Yi T, Danowski M
Am J Hum Genet. 2023; 110(11):1841-1852.
PMID: 37922883
PMC: 10645559.
DOI: 10.1016/j.ajhg.2023.10.001.
Determining the utility of diagnostic genomics: a conceptual framework.
Mallett A, Stark Z, Fehlberg Z, Best S, Goranitis I
Hum Genomics. 2023; 17(1):75.
PMID: 37587497
PMC: 10433656.
DOI: 10.1186/s40246-023-00524-1.
Artificial intelligence and digital pathology: clinical promise and deployment considerations.
Zarella M, McClintock D, Batra H, Gullapalli R, Valante M, Tan V
J Med Imaging (Bellingham). 2023; 10(5):051802.
PMID: 37528811
PMC: 10389766.
DOI: 10.1117/1.JMI.10.5.051802.
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease.
Smith J, Schaid D, Kullo I
Curr Atheroscler Rep. 2023; 25(6):323-330.
PMID: 37223852
PMC: 10495216.
DOI: 10.1007/s11883-023-01104-3.
Public knowledge of and attitudes toward genetics and genetic testing in Brunei Darussalam.
Jaya H, Matusin S, Mustapa A, Abdullah M, Hamid M
Front Genet. 2023; 14:1181240.
PMID: 37168509
PMC: 10165734.
DOI: 10.3389/fgene.2023.1181240.
Spectrum of congenital and inherited ocular disorders seen in a genetic clinic: Experience of a developing ocular genetic service.
Sahu A, Kaur S, Sukhija J, Srivastava P, Kaur A
Indian J Ophthalmol. 2023; 71(3):935-940.
PMID: 36872713
PMC: 10229979.
DOI: 10.4103/ijo.IJO_1177_22.
Predictive Value of c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users.
Jansen M, Rigter T, Fleur T, Souverein P, Verschuren W, Vijverberg S
Genes (Basel). 2023; 14(2).
PMID: 36833383
PMC: 9957000.
DOI: 10.3390/genes14020456.
Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores.
Chapman C
J Community Genet. 2022; 14(5):441-452.
PMID: 36529843
PMC: 10576696.
DOI: 10.1007/s12687-022-00625-9.
Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
Hayeems R, Bernier F, Boycott K, Hartley T, Michaels-Igbokwe C, Marshall D
BMJ Open. 2022; 12(10):e061468.
PMID: 36216418
PMC: 9557316.
DOI: 10.1136/bmjopen-2022-061468.
Pathogenic variants in arteriopathy genes detected in a targeted sequencing study: Penetrance and 1-year outcomes after return of results.
Sherafati A, Elsekaily O, Saadatagah S, Kochan D, Lee C, Wiesner G
Genet Med. 2022; 24(10):2123-2133.
PMID: 35943490
PMC: 9837827.
DOI: 10.1016/j.gim.2022.07.007.
Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
Arias J, Lin G, Tyler A, Douglas M, Phillips K
J Alzheimers Dis. 2022; 90(3):1011-1019.
PMID: 35871355
PMC: 9712158.
DOI: 10.3233/JAD-220674.
